BALSALAZIDE DISODIUM
| Brand name | COLAZAL |
|---|---|
| Active ingredient | BALSALAZIDE DISODIUM |
| Strength | 750MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2000 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7452872*PED | February 2027 | — |
| 7625884*PED | February 2027 | — |
| 7625884 | August 2026 | use U-141 |
| 7452872 | August 2026 | use U-141 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.